Orange Book product · Brand (NDA)
TRAVATAN
TRAVOPROST
At a glance
Mar 16, 2001
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 16, 2001
25 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
TRAVOPROST
Strength
0.004% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 021257
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023IDOSE TRBrand (NDA)
NDA 218010 · GLAUKOS
- 2014IZBABrand (NDA)
NDA 204822 · NOVARTIS
- 2006TRAVATAN ZBrand (NDA)
NDA 021994 · SANDOZ
- 2025TRAVOPROSTGeneric (ANDA)
ANDA 214687 · ALEMBIC
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 217228 · SOMERSET THERAPS LLC
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 218159 · GLAND
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 207040 · LUPIN
- 2021TRAVOPROSTGeneric (ANDA)
ANDA 203767 · MICRO LABS
- 2019TRAVOPROSTGeneric (ANDA)
ANDA 210458 · ALEMBIC
- 2017TRAVOPROSTGeneric (ANDA)
ANDA 205050 · MYLAN
- 2015TRAVOPROSTGeneric (ANDA)
ANDA 203431 · APOTEX
- 2013TRAVOPROSTGeneric (ANDA)
ANDA 091340 · CHARTWELL RX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
